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Abstract
Background: Childhood pneumonia and bronchiolitis is a leading cause of illness and death in young children
worldwide with Respiratory Syncytial Virus (RSV) as the main viral cause. RSV has been associated with annual
respiratory disease outbreaks and bacterial co-infection has also been reported. This study is the first RSV
epidemiological study in young children hospitalized with community-acquired pneumonia (CAP) in Belém city,
Pará (Northern Brazil).
Methods: With the objective of determining the prevalence of RSV infection and evaluating the patients’ clinical
and epidemiological features, we conducted a prospective study across eight hospitals from November 2006 to
October 2007. In this study, 1,050 nasopharyngeal aspirate samples were obtained from hospitalized children up to
the age of three years with CAP, and tested for RSV antigen by direct immunofluorescence assay and by Reverse
Transcription Polymerase Chain Reaction (RT-PCR) for RSV Group identification.
Results: RSV infection was detected in 243 (23.1%) children. The mean age of the RSV-positive group was lower
than the RSV-negative group (12.1 months vs 15.5 months, p<0.001) whereas gender distribution was similar. The
RSV-positive group showed lower means of C-reactive protein (CRP) in comparison to the RSV-negative group
(15.3 vs 24.0 mg/dL, p<0.05). Radiological findings showed that 54.2% of RSV-positive group and 50.3% of
RSV-negative group had interstitial infiltrate. Bacterial infection was identified predominantly in the RSV-positive
group (10% vs 4.5%, p<0.05). Rhinorrhea and nasal obstruction were predominantly observed in the RSV-positive
group. A co-circulation of RSV Groups A and B was identified, with a predominance of Group B (209/227).
Multivariate analysis revealed that age under 1 year (p<0.015), CRP levels under 48 mg/dL (p<0.001) and bacterial
co-infection (p<0.032) were independently associated with the presence of RSV and, in the analyze of symptoms,
nasal obstruction were independently associated with RSV-positive group (p<0.001).
Conclusion: The present study highlights the relevance of RSV infection in hospitalized cases of CAP in our region;
our findings warrant the conduct of further investigations which can help design strategies for controlling the
disease.
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Background
Globally, RSV is the most common cause of childhood
acute lower respiratory infection and is responsible for
annual outbreaks worldwide [1-4]. RSV infection usually
results in upper respiratory tract illness characterized by
profuse rhinorhea, however 25 – 40% of children experi-
encing infections in their first year of life may develop
severe respiratory disease requiring hospitalization
[1,5,6]. This may result in long-term respiratory disor-
ders such as abnormal pulmonary function, asthma, re-
current cough, and bronchitis [7,8]. RSV has two
Groups, A and B, which are distinguished largely by
antigenic and genetic characteristics. During epidemics,
either Group A or B may predominate, or both Groups
may circulate concurrently [7,9]. Evidence for RSV infec-
tion has been found in every geographic area studied
and the predominant occurrence changes according to
the region’s climates. In temperate countries RSV out-
breaks coincide with winter and in tropical climates the
pattern varying with most literature associating RSV
with rainy season [10-13].
Pneumonia is among the main causes of illness and
death in the younger children throughout the world [14-
16]. There is the need for a better assessment of the epi-
demiology of viral CAP in developing countries where
RSV infections substantially account for epidemics and
are associated with a more severe clinical presentation
of pneumonia [4]. Some retrospective studies investi-
gated the occurrence of bacterial coinfection in children
hospitalized with severe RSV infection and found the in-
cidence of pulmonary bacterial coinfection to vary be-
tween 17.5 and 44% [15,17,18].
To our knowledge, this is the first RSV epidemio-
logical study in children hospitalized with CAP in Belém
city, Pará, Northern Brazil, to assess the epidemiological,
clinical, and laboratory features of RSV infections among
infants and young children. Moreover we sought to
characterize the circulating RSV Groups in our region.
Methods
Study population
Patients’ clinical and epidemiological data were obtained
during a cross-sectional study comprising eight hospitals
carried out between November 2006 and October 2007,
in Belém, Pará, located in the Northern tropical area of
Brazil. We investigated for RSV infection in hospitalized
children with CAP. This condition was as defined by
medical practitioners of the project based on (A), (B) and
(C). (A) Two clinical findings: cough, history of fever,
pleuritic pain, crackles or bronchial breath sounds; (B)
Chest radiographic findings consistent with pneumonia
(focal airspace consolidation, patchy increased interstitial
markings), and (C) patients admitted with less than 48
hours. The last condition was used to exclude patients
had been infected with pneumonia after being admitted
to the hospital. Patients were included in this study if the
following criteria were met: children up to the three years
old, hospitalized, diagnosed with CAP and with a signed
consent form obtained from parents or legal guardians at
enrolment. This study was approved by the Ethics and
Research Committee of Evandro Chagas Institute (IEC)
in the context of a large prospective study that investi-
gates the etiology of CAP in different countries.
Sample collection
Nasopharyngeal aspirate samples were collected by vac-
uum suction through a plastic catheter and refrigerated
at 4°C until transported on ice to the Respiratory Virus
Laboratory at IEC. At the institute, the samples were
processed within two hours for RSV antigen detection
using the Direct Immunofluorescence Assay (DFA).
RSV-positive samples were subsequently subjected to
RT-PCR for the detection of the RSV Group.
Demographic data and clinical symptoms were also
obtained. A questionnaire was filled by a trained techni-
cian including age, onset of symptoms, gender, blood
bacterial culture, chest radiography, C-Reactive Protein
(CRP) levels, and signs or symptoms of cough, rhinor-
rhea, fever, nasal obstruction, vomiting and diarrhea
were analyzed at the time of hospitalization.
Direct immunofluorescence assay (DFA)
DFA was carried out using specific monoclonal anti-
bodies for the detection and identification of RSV in dir-
ect respiratory specimen cell preparation with Light
DiagnosticsTM Respiratory Syncytial Virus DFA kit, cat.
3125 (ChemiconW International, Inc. Temecula, CA), in
accordance with the manufacturer’s instructions.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR was performed to detect RSV RNA sequence
and identify RSV Groups in samples that were positive
by DFA. Primers were adopted from Canducci et al.
[19]. Total RNA was extracted directly from supernatant
specimens with the QIAampW Viral RNA Mini Kit, cat.
52904 (Qiagen) and the amplification and detection were
performed with SuperScriptTM One-step RT-PCR and
the Platinum TaqW comercial Kit, cat. 10928–034 (Invi-
trogen Life Technologies, CA, USA). The primers used
for group determination were generated against the F
regions of the RSV genome. Positive control and water
as a negative control were run together in each RT-PCR
assay to validate the amplification process and to ex-
clude the presence of contaminants.
C-reactive protein (CRP)
CRP levels were determined from serum samples of
patients and stored up to 4 days at about 4°C, until the
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completion of qualitative and semi-quantitative survey,
by agglutination of latex particles using the Serolatex
PCR kit, cat. 56 (Labtest Diagnóstica S.A., Brazil), in ac-
cordance with the manufacturer’s instructions.
Radiographs
The radiological assessment was performed by three in-
dependent physicians blinded to the patient’s condition,
with reading of the radiographs standardized for all.
Radiological typical for CAP included interstitial infil-
trate, alveolar infiltrate, and lobar pneumonia.
Statistical analyses
Patients were divided into two groups according to DFA
results and the analysis was performed using Statistical
Package for the Social Sciences (SPSS, version 17.0, Inc.,
Chicago, IL), for Windows. Fisher’s exact test was used
adjunctively if the expected values were less than 5. The
student’s t test was applied to compare means.
Multivariate analysis was performed using logistic re-
gression models. Variables with a p value <0.1 in univari-
ate analysis were entered in the multivariate analysis.
The level of significance was set at <0.05. The both ana-
lyses (1 and 2) including pneumonia positive and nega-
tive for RSV as the dependent variable. (1) was a
comparison of pneumonia by RSV positive and negative
group included the following independents variables:
age, gender, CRP levels and bacterial culture; (2) was a
comparison of pneumonia positive and negative for RSV
and the signs and symptoms reported at hospitalization
included the following variables: cough, rhinorrhea,
fever, nasal obstruction, vomiting and diarrhea.
Results
The inclusion criteria were met by 1,214 patients with
CAP during the period of study, of whom 1,050
(86.49%) had consent from parents or legal guardians
to participate. The differences in distribution of demo-
graphic characteristics and admission diagnoses were
not statistically significant for those who declined rela-
tive to those who participate in the study (data not
shown). RSV DFA results were available for all 1,050
patients included in the study. The prevalence of RSV
infection was 23.1% (243/1,050 patients). Demographic
and clinical features of RSV- positive and RSV-negative
children are shown in Table 1. In terms of age, the
average of RSV-positive group (12.1 months) was lower
than that of the RSV-negative group (15.5 months)
(p<0.001). There was no statistically significant differ-
ence between the groups in relation to gender (51.8%
male and 48.2% female). Among the patients who had
CRP levels analyzed (810/1.050, 77.1%), the RSV-
positive group showed a lower mean level in compari-
son to the RSV-negative group (p<0.001). The chest
radiological findings have shown that 54.2% of RSV-
positive and 50.3% of RSV-negative patients developed
interstitial infiltrate. Bacterial culture were available for
46.7% of study participants (490/1.050). Although the
90.0% of RSV-positive patients yielded negative bac-
teriological culture, bacterial co-infection was identified
in this group with 10.0% of culture growth, while the
RSV-negative group showed only 4.5% growth (p<0.05)
(Table 1).
It was possible to determine the RSV Group in 227
(93.4%) out of 243 RSV-positive samples. RSV Group B
infections predominated RSV Group A (209 vs 18
Table 1 Epidemiologic, clinical, and laboratory characteristics of RSV-positive and RSV-negative children hospitalized
for community-acquired pneumonia in Belém, Para, Brazil
Characteristics RSV- positive 243 (23.1%) RSV-negative 807 (76.9%) Groups (n)
n % n % p A B p
Age (years)
0 - 1 152/241 63.1 340/805 42.1 <0.001 10/18 135/207 0.282
Gender
Male 126/243 51.8 449/807 55.6 0.113 9/18 108/207 0.542
C-Reactive protein
≤48 mg/dL 155/178 87.0 469/632 74.2 <0.001 9/13 133/151 <0.001
Radiographs
Interstitial infiltrate 117 54.2 366 50.3 0.085 9 102 0.235
Alveolar infiltrate 49 22.7 164 22.5 1 45
Lobar pneumonia 50 23.1 198 27.2 5 39
Bacterial culture
Positive 11Δ/109 10.0 17*/381 04.5 0.043 1/8 10/92 0.342
Δ S. epidermidis (3 patients), A. baumannii (2), S. pneumoniae (1), Com. acidovorans (1), K. pneumoniae (1), Gram Positive (1), Candida spp (1), other fungi (1).
* S. pneumoniae (4 patients), S. epidermidis (3), Tetrads (3), Gram Positive (3), K. pneumoniae (2), S. viridians (1), A. baumannii (1).
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patients, respectively). Group B infection was associated
with a lower age than Group A (11.0 vs 13.0 months;
p<0.03). With regards to the CRP levels, Group B infec-
tion showed a lower CRP mean when compared to
Group A (11.0 vs 19.0 mg/dL, p<0.05). Gender, radio-
logical pattern, bacterial culture and the onset of symp-
toms denoted a similar distribution in both Groups.
We described the signs and symptoms in Table 2 for
RSV-positive and RSV-negative groups. Approximately
98% of RSV-positive children had a cough at admission
but no statistically significant difference was observed
when compared to the RSV-negative group (96.1%;
p>0.05). Five clinical parameters showed significantly
different rates (p<0.05) when comparing both groups:
fever, vomiting and diarrhea were detected predomin-
antly in the RSV-negative group (80.2% vs 72.4%, 12.2%
vs 4.9% and 8.1% vs 4.1%, respectively), while rhinorrhea
and nasal obstruction were predominantly observed in
RSV-positive group (78.2% vs 71.5% and 59.2% vs 32.8%,
respectively, both comparisons yielding a p<0.05).
Patients infected with either A or B Groups did not sig-
nificantly differ in terms of signs and symptoms.
Figure 1 shows that RSV infection was detected from
January to July 2007, with higher prevalence rates
observed from April (48.6%) to June 2007 (52.4%).
The Multivariate Analysis of Risk Factors for RSV
CAP showed in analyze (1) the age under 1 year (OR
1.36; 95% CI; 1.06–1.74; p<0.015), CRP levels under
48 mg/dL (OR 3.49; 95% CI; 1.80–6.77; p<0.001) and
bacterial co-infection (OR 2.57; 95% CI; 1.08–6.09;
p<0.032) were independently associated with the pres-
ence of RSV as opposed to RSV-negative group. In
analyze (2) only nasal obstruction was independently
associated with presence of RSV (OR 3.07; 95%
CI; 2.24–4.21; p<0.001) (Table 3).
Discussion
The detection of RSV in 23.1% of the samples in our
study denoted a prevalence rate similar to those
observed in other studies on the occurrence of lower re-
spiratory tract infection, ranging from 23% to 61%
[6,20,21]. The possible limitation of the study was the
use of a less sensitive method (IF) as compared to RT-
PCR that has shown improved sensitivity in the detec-
tion of RSV infection [14,22]. In fact there is differential
detection related to viral load. Infants usually have se-
vere RSV disease associated with higher viral load hence
a better chance of detection compared to the older
counterparts leading to a differential misclassification
(BIAS) [23]. However, the large number of samples ana-
lyzed in this study minimizes the bias and did not alter
the statistical significance of our results.
RSV has been referred in the literature as the main
agent responsible for bronchiolitis and pneumonia dur-
ing the first year of life. According to our study, 62.5% of
children were younger than one year old, suggesting that
illnesses caused by RSV can be severe in this age group,
thus requiring hospitalization with prompt and effective
medical intervention [5,24].
Gender was not identified as a significant risk factor
for RSV infection in our study in agreement with other
published studies [21,25]. Nevertheless, some findings in
the literature have shown a male predominance, as
reported by D’Elia et al. [5], particularly between 0 and
2 months.
Evaluation of CRP is very useful for clinicians because
it may help differentiate between bacterial and viral eti-
ologies. Shin et al. [26] used levels of CRP (≥1.87 mg/dL)
as criteria to rule out serious bacterial infection in infants
from self-limiting viral illness in febrile infants younger
than three months. Diniz et al. [25] also found a statisti-
cally significant difference between nosocomial viral
lower respiratory tract infection and levels of CRP less
than or equal to 40 mg/L. In our study, the RSV-positive
group showed a lower CRP mean level when compared
to the RSV-negative group. Thus, low CRP levels may
suggest a viral infection and, depending upon the clinical
and radiological findings, enables the suspension of anti-
biotic therapy and helps considerably in the reduction of
the hospital stay.
The radiological findings in our study have shown that
54.2% of RSV-positive patients developed interstitial
Table 2 Signs and symptoms reported at hospitalization in RSV-positive and RSV-negative patients with
community-acquired pneumonia and detected RSV Groups
RSV-positive 243 (23.1%) RSV-negative 807 (76.9%) Groups
n % n % p A B p
Cough 238 97.9 714 96.1 0.056 100% 98.5% 0.779
Rhinorrhea 190 78.2 531 71.5 0.002 83.3% 77.8% 0.443
Fever 176 72.4 596 80.2 0.009 83.3% 71.8% 0.323
Nasal obstruction 144 59.2 244 32.8 <0.001 66.6% 58.7% 0.359
Vomiting 12 04.9 91 12.2 <0.001 0 4.8% 0.428
Diarrhea 10 04.1 60 08.1 0.023 0 14.8% 0.428
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infiltrate. Diniz et al. [25] found a significant correlation
between nosocomial viral lower respiratory tract infec-
tion and interstitial infiltrate and it was observed that all
patients with confirmed bacterial, fungal, or mixed infec-
tion presented alveolar infiltrate.
We found a predominance of RSV infection without
bacterial co-infection in our study, in agreement with
Duttweiler et al. [27] who found that concomitant bac-
terial sepsis was a rare event in 127 hospitalized RSV
infected infants. However, when we compared the
groups, positive culture was predominantly observed in
the RSV-positive group than the RSV-negative group
(10.0% vs 4.5%, p<0.028). Thorburn et al. [15] reported
on pulmonary bacterial co-infection in children with se-
vere RSV bronchiolitis showing that 40% of children
with severe RSV infection were infected with bacteria in
their lower airways. Unfortunately, we were unable to
demonstrate if these infections would be either second-
ary or concurrent to viral infection.
It was possible to determine the RSV Group in 227
(93.4%) samples, and 6.6% were untypable probably due
to problems in processing samples or RNA extraction.
This study reports predominance of RSV Group B infec-
tion in children hospitalized with CAP, which is not un-
usual in other regions [9,28]. Unfortunately, our data
presents some limitation since we could collect samples
for only one year and annual RSV Group epidemic may
change. Suwanjutha et al. [28] identified in the first year
of study the predominance of Group B, in contrast to
the second year when Group A was more predominant.
Due to the high number of RSV Group B infection,
comparison with.Group A (only 18 children) epidemio-
logical data is not conclusive. However, in our findings,
Group B was found among children with a mean age
lower than that for Group A (11.0 vs 13.0; p<0.03), a
finding similar to that of Papadopoulos et al. [29] who
reported a predominance of RSV B infection in the
youngest children, but the reasons are still unknown.
Mlinaric-Galinovic et al. [9] and Oliveira et al. [8] did
not find age differences between Groups, even though
Mlinaric-Galinovic et al. [9] found that Group B infec-
tions occurred more frequently in males less than
12 months of age than in females. Oliveira et al. [8] on
the other hand, found that the 57.8% of RSV A-infected
children were male. Unfortunately, there is no plausible
explanation for this variation.
We were able to determine that the CRP mean level in
Group B was lower than Group A (13.0 vs 19.0; p<0.05)
but the reasons for this remain unknown. Further re-
search with an adequate number of samples needs to be
conducted in an attempt to better understand RSV
Groups in cases of CAP and their association with the
epidemiological data of patients.
We have evaluated the signs and symptoms and ap-
proximately 98% of RSV-positive cases had cough at ad-
mission, but no statistically significant difference was
observed in comparison with RSV-negative group
(96.1%) (p>0.05). Rhinorrhea and nasal obstruction were
predominantly observed in the RSV-positive group
(p<0.05). Regarding the clinical signs and symptoms
observed by Diniz et al. [25] in São Paulo city, in the
preterm infants infected with RSV, wheezing, rhinorrhea,
vomiting, and diarrhea were significantly more frequent
while in our study vomiting and diarrhea were detected
predominantly in RSV-negative group. In addition, the
Table 3 The Multivariate Analysis of Risk Factors for RSV
infection in patients hospitalized with community-
acquired pneumonia
Analyzes p OR 95% CI
Lower Upper
Signs and symptoms
Fever 0.109 0.754 0.535 1.065
Rhinorrhea 0.798 0.952 0.654 1.386
(1) Nasal obstruction <0.001 3.075 2.244 4.215
Cough 0.107 2.428 0.825 7.146
Diarrhea 0.646 0.836 0.390 1.794
Vomiting 0.078 0.551 0.283 1.069
Characteristics
CRP <48 mg/dL <0.001 3.498 1.807 6.772
(2) Bacterial co-infection 0.032 2.570 1.081 6.094
Age <1 year 0.015 1.361 1.062 1.745
Male gender 0.476 1.186 0.742 1.895
(1) (2) pneumonia positive and negative for RSV as the dependent variable.
Figure 1 Monthly prevalence of Respiratory Syncytial Virus
(RSV) in children up to three years old, hospitalized with
community-acquired pneumonia (CAP), from November 2006
to October 2007.
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clinical symptoms do not predict the viral etiology be-
cause there are difficulties in establishing the general
etiologic diagnoses of pneumonia by clinical profiles,
which are quite varied in literature and depend on the
infectious agent as well as the age and immune state of
the host.
With regards to the seasonality, our study showed that
RSV activity in hospitalized children during January to
July 2007, with a peak during April to June, coincided
with a heavy rainfall period in the region. Outbreaks oc-
curring mainly during the months with low tempera-
tures were reported in Uberlandia (Midwestern Brazil)
by Costa et al. [30]. This seasonal pattern was also
observed in other Brazilian settings where RSV occur-
rence is not uniform. This has been noted in several Bra-
zilian geographic regions and even among different
states in the same region [10]. In Campinas (São Paulo)
[21] and in Vitória (Espírito Santo) [31], South-eastern
region, the annual highest incidence of RSV-infections
occurred between January and June, the same period of
months observed in our study.
A greater understanding of the factors that determine
RSV activity would make this timing even more precise.
However, such studies are important as they are
expected to delineate the clinical and epidemiological
behavior of RSV in this age range and in this region.
Even though our study presents a low prevalence of bac-
terial co-infection among the RSV-positive patients,
monitoring RSV activity is necessary in order to restrict
antibiotic use to the infants in real need and to provide
better prophylactic therapies.
Conclusion
In conclusion, to our knowledge this is the first report of
RSV infection in hospitalized children with CAP in our
region. We highlighted that the RSV infection preva-
lence associated with CAP in Northern Brazil is similar
to those found in other regions and other countries.
However, according to current findings and those
reported in the literature, it may be concluded that the
lower mean of age as well as the lower levels of CRP are
characteristics found in viral infections of these cases in
Belém city. The signs and symptoms associated with
RSV in our study were rhinorrhea and nasal obstruction,
even though divergent in the literature, and the predom-
inant RSV Group identified was B. Furthermore, the data
provided by the study indicate that there is a need for con-
tinuous efforts in order to broaden our knowledge on the
epidemiological aspects of RSV infection and CAP.
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